Delaware Clinical and Translational Research ACCEL Program (Admin Core)
特拉华州临床和转化研究 ACCEL 计划(管理核心)
基本信息
- 批准号:10721012
- 负责人:
- 金额:$ 109.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-25 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdministrative EfficiencyAmericanAwardBiometryBlack raceBusinessesChild HealthClinical ResearchCollaborationsCommunicationCommunity OutreachDataDecision MakingDelawareDevelopmentEnsureEpidemiologyEvaluationExtramural ActivitiesFundingGoalsGrowthHealthHealthcareHealthcare SystemsInstitutionMedicalMissionOccupational activity of managing financesPediatric HospitalsPerformancePilot ProjectsProductivityRegulationResearch DesignResearch InfrastructureResearch PersonnelResourcesSouth CarolinaStructureTranslational ResearchTrustUniversitiesWorkclinical infrastructurecommunity engagementexpectationflexibilityhealth equityhealth inequalitieshealth organizationimplementation facilitationimprovedoperationprogramssoundsuccesstranslational research program
项目摘要
ABSTRACT- ADMINISTRATIVE CORE
The ACCEL CTR Program has successfully met the expectations of this award mechanism by expanding
the capacity for clinical and translational research in Delaware and enhancing our investigators’ ability to
successfully compete for extramural funding in this arena. The success of ACCEL is anchored in the
complementary strengths of the partnership network been built over the past nine years. Our current
network consists of the University of Delaware (lead institution), Christiana Care Health System,
Nemours Children’s Health and Delaware State University—an American, historically Black, public
university. To date, ACCEL has established an exceedingly strong network and infrastructure for clinical
and translational research within Delaware; and, we are now poised and ready to continue our growth
trajectory by building a deeper focus on health equity into our clinical and translational research
infrastructure. The planned components of the ACCEL Program include the Administrative Core and five
other required Cores, including: the Professional Development Core; the Biostatistics, Epidemiology, &
Research Design Core; the Community Engagement & Outreach Core; the Pilot Projects Program, and
the Tracking and Evaluation Core. The overall goal of the Administrative Core is to improve the
efficiency, productivity and impact of the five other Cores so that we are able to successfully meet our
common mission of building clinical and translational research infrastructure that will be sustainable and
ultimately improve the health of Delawareans. We believe that we have a very effective administrative
structure that does not require substantial change. But, in this renewal application, we propose an
exciting new addition to the Administrative Core—a Health Equity Navigator, who will work closely with all
Core leaders to weave the thread of health equity throughout all aspects of the ACCEL program. The
Health Equity Navigator will keep the network focused on health equity as we strengthen our clinical and
translational research infrastructure. The Specific Aims of the Administrative Core are to continue to: (1)
Provide a flexible and efficient administrative and governance structure that enhances the DE-CTR
ACCEL Program’s ability to grow and sustain clinical and translational research programs that address
the most important health care needs of Delawareans and all Americans; (2) Manage the financial and
business operations of the DE-CTR ACCEL Program to ensure operational efficiency, sound fiscal health
of the organization and compliance with all federal, state and local regulations; (3) Enhance and promote
data-informed decision-making, communication and collaboration across all ACCEL components,
participating institutions and other IDeA programs; and (4) Facilitate the implementation of strategic, high-
value initiatives that will enhance the ACCEL Program’s ability to address health inequities and improve
infrastructure for clinical and translational research within the state of Delaware.
抽象行政核心
Accel CTR计划成功地满足了这一奖励机制的期望,通过扩展
特拉华州的临床和转化性研究的能力,并增强我们的研究人员的能力
在这个竞技场上成功争取到外部资金。Accel的成功植根于
在过去九年中,建立了伙伴关系网络的优势互补。我们目前的情况
网络由特拉华大学(牵头机构)、克里斯蒂娜保健保健系统、
内穆斯儿童健康与特拉华州立大学--美国历史上的黑人公立大学
上大学。到目前为止,Accel已经为临床建立了非常强大的网络和基础设施
和特拉华州的翻译研究;我们现在已经准备好继续我们的增长
通过在我们的临床和转化性研究中更深入地关注健康公平来实现这一轨迹
基础设施。Accel计划的计划组成部分包括管理核心和五个
其他所需核心,包括:专业发展核心;生物统计学、流行病学和
研究设计核心;社区参与和推广核心;试点项目计划;以及
跟踪和评估核心。行政核心的总体目标是改善
效率、生产力和其他五个核心的影响,使我们能够成功地满足我们的
建设可持续的临床和转化性研究基础设施的共同使命
最终改善特拉华州人的健康。我们相信,我们有一个非常有效的行政管理
不需要实质性改变的结构。但是,在这次续签申请中,我们提出了一项
令人振奋的行政核心新成员-健康公平导航员,将与所有
核心领导在Accel计划的所有方面都编织了卫生公平的线。这个
Health Equity Navigator将使网络继续关注健康公平,因为我们将加强我们的临床和
翻译研究基础设施。行政核心的具体目标是继续:(1)
提供灵活和高效的行政和治理结构,以加强DE-CTR
Accel计划发展和维持临床和转化性研究计划的能力
特拉华州人和所有美国人最重要的医疗保健需求;(2)管理财务和
DE-CTR Accel方案的业务运作,以确保运营效率、稳健的财政状况
组织和遵守所有联邦、州和地方法规;(3)加强和促进
跨所有Accel组件的数据知情决策、通信和协作,
参与机构和其他创意方案;以及(4)促进实施战略性、高效率的
重视将增强Accel计划解决卫生不平等问题的能力并改善
特拉华州内的临床和转化性研究基础设施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory E Hicks其他文献
Gregory E Hicks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory E Hicks', 18)}}的其他基金
Turning the TiDe: Training Diverse Clinician Scientists in Rehabilitation Research
扭转局势:培训康复研究领域的多元化临床科学家
- 批准号:
10686197 - 财政年份:2022
- 资助金额:
$ 109.2万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10437677 - 财政年份:2013
- 资助金额:
$ 109.2万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program (Admin Core)
特拉华州临床和转化研究 ACCEL 计划(管理核心)
- 批准号:
10892513 - 财政年份:2013
- 资助金额:
$ 109.2万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10885455 - 财政年份:2013
- 资助金额:
$ 109.2万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10841849 - 财政年份:2013
- 资助金额:
$ 109.2万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10721011 - 财政年份:2013
- 资助金额:
$ 109.2万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program-Admin Core
特拉华州临床和转化研究 ACCEL 计划-管理核心
- 批准号:
10437678 - 财政年份:2013
- 资助金额:
$ 109.2万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10372245 - 财政年份:2013
- 资助金额:
$ 109.2万 - 项目类别:
Resveratrol for the prevention of bone loss in postmenopausal women with osteopenia
白藜芦醇预防绝经后骨质减少女性骨质流失
- 批准号:
10728055 - 财政年份:2013
- 资助金额:
$ 109.2万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10223322 - 财政年份:2013
- 资助金额:
$ 109.2万 - 项目类别:














{{item.name}}会员




